期刊文献+

精准纳米气体治疗研究进展 被引量:3

Progress of Precision Nanomedicine-mediated Gas Therapy
下载PDF
导出
摘要 精准纳米气体治疗具有低毒高效等特性,作为一种新兴的疾病治疗手段受到越来越多的关注。研究表明,纳米气体治疗不仅能在特定疾病部位选择性杀死癌细胞,还能保护正常细胞。本文总结了国际最新研究成果,对精准纳米气体治疗的最新研究进展进行了总结归纳和展望。首先,阐述了纳米气体治疗的治疗作用和特点;然后,总结了实现精准纳米气体治疗的主要途径,包括靶向气体传输、可控气体释放、医学成像引导和监控气体治疗、基于治疗性气体的多模式联合治疗等;最后,对纳米气体治疗存在的问题和发展前景做出了总结和展望。 The precision nanomedicine-mediated gas therapy as an emerging and promising therapy strategy has received increasing attention, due to its low toxicity and high efficacy. Recent studies show that the nanomedicine-mediated gas therapy can not only kill cancer cells in specific diseased sites, but also protect normal cells. This review summarizes and reviews the most recent progress of the nanomedicine-mediated gas therapy. We introduce the therapeutic effects and characteristics of the nanomedicine-mediated gas therapy firstly, and then review several main routes to realize the precision nanomedicine-mediated gas therapy, including targeted gas delivery, controlled gas release, biomedical imaging guidance-monitoring of gas therapy, multi-model combined therapy based on therapeutic gases, and so on, and finally summarize the present existing issues and the prospects of further development in the gas therapy field.
作者 何前军 陈丹阳 范明俭 HE Qian-Jun;CHEN Dan-Yang;FAN Ming-Jian(School of Biomedical Engineering,Health Science Center,Shenzhen University,Shenzhen 518060,China)
出处 《无机材料学报》 SCIE EI CAS CSCD 北大核心 2018年第8期811-824,共14页 Journal of Inorganic Materials
基金 国家自然科学基金(81701827) 深圳市基础研究项目(JCYJ20170302151858466) 深圳市孔雀团队项目(KQTD2016053112051497)~~
关键词 气体治疗 纳米药物 可控释放 药物传输 介孔二氧化硅 石墨烯 综述 gas therapy nanomedicine controlled release drug delivery mesoporous silica graphene review
  • 相关文献

参考文献1

二级参考文献36

  • 1Chen Q Z, Ahmed I, Knowles J C, et al. Collagen release kinetics of surface functionalized 4555 Bioglass-based porous scaffolds. J. Biomed. Mater Res. A, 2008, 86A(4): 987-995.
  • 2Erdinc N, Gokturk S, Tuncay W. Interaction of epirubicin HCI with surfactants: effect of NaC1 and glucose. J. Pharm. Sci., 2004, 93(6): 1566-1576.
  • 3Li X, Zhang L X, Dong X P, et al. Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior. Microporous. Mesoporous. Mater., 2007, 102(1/2/3): 151-158.
  • 4Oonishi H, Kushitani S, Yasukawa E, et al. Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin. Orthop. Relat. Res., 1997, 334: 316-325.
  • 5Oonishi H, Hench L L, Wilson J, et al. Comparative bone growth behavior in granules of bioceramic materials of various sizes. J. Biomed. Mater. Res., 1999, 44(1): 31-43.
  • 6Zhong J P, Greenspan D C. Processing and properties of Sol-Gel bioactive glasses. J. Biomed. Mater Res., 2000, 53(6): 694-701.
  • 7Wang T W, Wu H C, Wang W R, et al. The development of magnetic degradable DP-bioglass for hyperthermia cancer therapy. J. Biomed. Mater. Res. B, 2007, 83A: 828-837.
  • 8Geraci M, Birch J M, Alston R D, et al. Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005. Br. J. Cancer, 2007, 97: 1588-1594.
  • 9Schulman K L, Kohles J. Economic burden of metastatic bone disease in the US. Cancer, 2007, 109(11)" 2334-2342.
  • 10Anderson P, Salazar-Abshire M. Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives. Curr. Oncol. Rep., 2006, 8(6): 415-422.

共引文献6

同被引文献20

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部